Approvals & regulatory · first seen 23 Sep, updated 23 Sep

Pfizer India speaks up after Karnataka FDA crackdown, says patient safety is top priority

1 outlet Pfizer FDA

Pfizer India has stated that patient safety and product quality are their top priorities following FDA actions. The Karnataka FDA canceled 16 drug licenses and suspended eight others due to counterfeit drugs. A raid uncovered an illegal ope…

Summary from Economic Times - Pharmaceuticals.

Coverage 1 article · 1 outlet

Economic Times - Pharmaceuticals 23 Sep
Pfizer India speaks up after Karnataka FDA crackdown, says patient safety is top priority